| Aug 15 |
Praxis Precision Medicines (PRAX) Upgraded to Buy: What Does It Mean for the Stock?
|
| Aug 13 |
Praxis Precision Medicines, Inc. (PRAX) Q2 2024 Earnings and Corporate Update Call Transcript
|
| Aug 13 |
Praxis Precision Medicines, Inc. (PRAX) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 13 |
Praxis Precision Medicines GAAP EPS of -$1.74 beats by $0.57, revenue of $0.36M misses by $0.47M
|
| Aug 13 |
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Results
|
| Aug 7 |
Will Arcutis Biotherapeutics, Inc. (ARQT) Report Negative Earnings Next Week? What You Should Know
|
| Jul 17 |
C4 Therapeutics (CCCC) Soars 13.7%: Is Further Upside Left in the Stock?
|
| Jun 21 |
Baird sees Jazz study failure as positive for rival Praxis
|
| Jun 21 |
Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?
|
| Jun 20 |
Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure
|
